Phl p 2
Summary
Phl p 2 is a major respiratory pollen allergen present in Timothy grass (Phleum pratense), which is being recognized by more than 200 million people suffering from allergy worldwide. Phl p 2 is a representative of the large family of cross-reacting grass pollen allergens classified as grass allergens group 2/3. Phl p 2 is a 10- to 12-kDa non-glycosylated protein of 95–98 amino acid residue and has an average sequence identity of 60% with group 2 allergens from rye grass (Lolp II, LoZp III).
Recombinant Phl p 2 (rPhl p 2) was produced in Escherichia coli (E. coli). It was observed that around 60% of grass pollen allergic patients displayed specific IgE reactivity with the recombinant allergen and elicit histamine release from the sensitized individuals. Recombinant form of Phl p 2 had been found to compete with the natural protein for binding to specific IgEs indicating that it is immunologically equivalent to the natural allergens. IgE antibodies of allergic patients actually recognize the conformational epitopes present on Phl p 2. Potential cross-reactivity of Phl p 2 with other grass species has not been reported due to the lack of the presence of conserved epitopes.
Pediatric populations suffering from moderate allergic rhinitis (AR) are found to contain higher levels of Phl p 2 than those suffering from mild AR.
Epidemiology
Worldwide distribution
Phl p 2 is an allergen present in timothy grass pollen, which is being recognized by more than 200 million people suffering from allergy worldwide. A study used sera from European, Asian, and American subjects to assess the percentage of IgE directed to pollen extracts from nine different monocot species including rPhl p 1, rPhl p 2, rPhlp 5 of timothy grass and rBet v 2 of birch pollen. The study detected that among 68% grass pollen allergic patients, a high level of grass pollen-specific IgE (59%) sensitization occurred for the four recombinant allergens only. In a study in Sweden, ARC was found to be associated with timothy grass pollen allergens in adolescents (aged 13-15 years) with Phl p 1 being the key allergen sensitizer followed by Phl p 5, Phl p 4, Phl p 6, and Phl p 2. Similarly, a multicenter study on children in Germany detected the level of IgE sensitization of timothy grass allergens to be highest in Phl p1, followed by Phl p 5, and Phlp 2. In a pediatric European population, 32% were found to have positive skin prick test for Phl p 2. Among grass pollen allergy patients in Brazil, 76% were found to be sensitized for Phl p 2.
Clinical Relevance
Specific molecules
Phl p 2 is one of the principal allergen components of timothy grass that is considered to be the major elicitors of grass pollen allergy symptoms. A study in Greece assessing specific IgE levels to the clinically relevant timothy grass pollen allergens detected the level of Phl p 2 to be significantly higher (p= 0.043) in children with moderate AR than in children with mild AR indicating the ability of Phl p 2 to induce allergic symptoms in AR patients.
Successful expression of Phl p 2 was done in E. coli to produce rPhl p 2, which competes with the natural Phl p 2 for binding to specific IgEs suggesting that rPhl p 2 is immunologically equivalent to the natural allergens. rPhl p 2 is known to induce production of IgE specific to Phl p 2 in about 60% of grass pollen allergic patients leading to histamine release from these sensitized individuals. Another study with 95% of the sera containing detectable IgE to timothy extract determined increased prevalence of IgE reactivity towards different recombinant allergen components (rPhl p 1, 2, 4, 5, 6, 7, 11,12) with prevalence for rPhl p 2 being 55%.
Studies reported about development of vaccine using non-allergenic peptides from the IgE-binding sites of four major timothy grass pollen allergens (Phl p 1, Phl p 2, Phl p 5, Phl p 6), since these 4 allergens are found to be the most relevant allergens in patients with grass pollen allergy.
Cross-Reactivity
Timothy grass pollen allergens (Phl p 1 and Phl p 2) and corn allergen (Zea m1) contain similar expansin structural motif that mediate cell wall expansion in plant. Common epitopes of Phl p 1, Phl p 2, and Zea m 1 are located on the protein portions of these expansins. This indicates that the structural similarity of conserved surface patches can explain the clinically observed cross-reactivities of allergens. Timothy grass pollen allergen Phl p 2 is dominated by charged and polar residues that form tight contacts (some of them by hydrogen bonds) to the antibody.
The alignment of Phl p 2 sequence with nine homologous sequences present in the C-terminal domains of group 1 grass pollen allergens portrayed that only three epitope residues are fully conserved indicating the lack of probable cross-reactivity between Phl p 2 with other group 1 grass pollen allergens.
Phl p2 and Phl p 3 show moderate sequence identity and extremely different isoelectric points (Phl p 2: 4.6; pI Phl p 3: 8.9). However, the three-dimensional structure of both allergens is highly similar and there exists variable cross-reactivity between these two allergens and the IgE of the allergic patients. In fact, Phl p 2 and Phl p 3 allergens signify a family of cross-reactive allergens that are able to replace one another for diagnosis as well as for use in allergen-specific immunotherapy.
References
- Padvattan S., Flicker S., Schirmer T., Randow S., Roose G., V S. High-Affinity IgE Recognition of a Conformational Epitope of the Major Respiratory Allergen Phl p 2 As Revealed by X-Ray Crystallography. J Immunol. 2009;182:2141-51.
- Dolecek C., Vrtala S., Laffer S., Steinberger P., D. K. Molecular characterization of Phlp II, a major timothy grass (Phleum pratense) pollen allergen. FEBS Letters. 1993;335(3).
- De Marino S., Morelli MAC., Fraternali F., Tamborini E., G. M. An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen. Structure. 1999;7(8):943-51.
- Douladiris N., Garib V., Piskou K., Focke-Tejkl M., R. V. Molecular allergy diagnosis: A potential tool for the assessment of severity of grass pollen‐induced rhinitis in children.
- Niederberger V., Laffer S., Froschl R., Rumpold H., S. K. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen–specific IgE. J Allergy Clin Immunol. 1998;101(2):258-64.
- Sterner T., Uldahi A., Svensson A., Borres MP., S. S. IgE sensitization in a cohort of adolescents in southern Sweden and its relation to allergic symptoms. Clin Mol Allergy. 2019;17(6):1-10.
- Huang X., Tsilochristou O., Perna S., Hofmaler S., A. C. Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life. Allergy. 2018;73:421-30.
- Douladiris N., Garib V., Focke-Tejkl M., Valenta R., NG. P. Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid. Pediatr Allergy Immunol. 2018;30:59-65.
- de Sousa Moreira PF., Gangi K., Vieira FAM., Ynoue LH., B. L. Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients. PLoS ONE. 2015:1-12.
- Grotte M. In situ Localization of Pollen Allergens by Immunogold Electron Microscopy: Allergens at Unexpected Sites. Int Arch Allergy Immunol. 1999;118:1-6.
- Linhart B., Focke-Tejkl M., Weber M., Narayanan M., A. N. Molecular Evolution of Hypoallergenic Hybrid Proteins for Vaccination against Grass Pollen Allergy. J Immunol. 2015;194:4008-18.
- Rossi RE., Monasterolo G., Operti D., R. B. Evaluation of IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, and Phl p 5) in a random sample of patients with speci®c IgE to Phleum pratense. Allergy. 2000;55:181-4.
- Mari A. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiolgical and diagnostic data. Clin Exp Allergy 2003;33:43-51.
- Focke-Tejkl M., Weber M., Niespodziana K., Neubauer A., H. H. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2015;135:1207-17.
- Andersson K, Lidholm J. Characteristics and Immunobiology of Grass Pollen Allergens. Int Arch Allergy Immunol. 2003;130:87-107.
- Pablos I., Wildner S., Asam C., Walner M., G. G. Pollen Allergens for Molecular Diagnosis. Curr Allergy Asthma Rep. 2016;16(31):1-12.
- Subcommittee WIAN. Allergen Nomenclature.
- Schein CH., Ivanciuc O., Horiuti TM., Goldblum RM., Braun W. An Allergen Portrait Gallery: Representative Structures and an Overview of IgE Binding Surfaces. Bioinformatics and Biology Insights. 2010;4:113-25.
- Hatzler L., Panetta V., Lau S., Wagner P., L. B. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol. 2012;130:894-901.
- Devanaboyina SC., Cornelius C., Lupinek C., Fauland K., F. DA. High-resolution crystal structure and IgE recognition of the major grass pollen allergen Phl p 3. Allergy. 2014;69(12):1627-8.